NYSE:HIMSHealthcare
A Look At Hims & Hers Health (HIMS) Valuation As Amazon Targets The Weight Loss Segment
Hims & Hers Health (HIMS) is back in focus after Amazon Pharmacy said it will offer Novo Nordisk’s Wegovy weight loss pill, sharpening competition in a category Hims & Hers has been building into.
See our latest analysis for Hims & Hers Health.
The Amazon Pharmacy move comes after a choppy stretch for Hims & Hers, with a 30 day share price return decline of 13.46% and a 90 day share price return decline of 48.69%. However, the 1 year total shareholder return of 22.85% and the 3 year total...